Thelin Gets EMEA Committee Approval Recommendation
This article was originally published in The Pink Sheet Daily
Executive Summary
The European Medicines Agency's Committee for Medicinal Products for Human Use recommended marketing authorization approval of Encysive's pulmonary arterial hypertension therapy Thelin (sitaxsentan), the agency announced June 2